Central composite design–based optimization, fabrication, and pharmacodynamic assessment of sulfasalazine-loaded lipoidal nanoparticle-based hydrogel for the management of rheumatoid arthritis

[1]  I. Kaur,et al.  In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery , 2022, Drug Delivery and Translational Research.

[2]  N. Verma,et al.  Investigating nanostructured liquid crystalline particles as prospective ocular delivery vehicle for tobramycin sulfate: Ex vivo and in vivo studies , 2021, Journal of Advanced Pharmaceutical Technology & Research.

[3]  Siti Khadijah Adam,et al.  Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir , 2021, Molecules.

[4]  A. Almeida,et al.  Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation , 2021, Pharmaceutics.

[5]  Y. Shin,et al.  Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry , 2021, Molecules.

[6]  Upendra Nagaich,et al.  Colon Targeted Protein Nanoparticles Loaded Suppositories : Effective against Intestinal Parasites , 2020, Advanced pharmaceutical bulletin.

[7]  M. Koland,et al.  Topical Delivery of Fenugreek Seed Extract Loaded Solid Lipid Nanoparticles Based Hydrogels for Alopecia , 2021, Journal of Pharmaceutical Research International.

[8]  Suman Jain,et al.  Development of nitazoxanide-loaded colon-targeted formulation for intestinal parasitic infections: centre composite design-based optimization and characterization , 2020, Future Journal of Pharmaceutical Sciences.

[9]  A. Dhar,et al.  A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems , 2020, RSC advances.

[10]  C. Patra,et al.  Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study , 2020, Drug development and industrial pharmacy.

[11]  Venkateshwaran Krishnaswami,et al.  Correction to: Development of Methotrexate and Minocycline Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis , 2020, AAPS PharmSciTech.

[12]  R. Sarkar,et al.  Sulfasalazine in dermatology: A lesser explored drug with broad therapeutic potential , 2020, International journal of women's dermatology.

[13]  Venkateshwaran Krishnaswami,et al.  Development of Methotrexate and Minocycline-Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis , 2019, AAPS PharmSciTech.

[14]  Venkateshwaran Krishnaswami,et al.  Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis , 2019, Applied Nanoscience.

[15]  M. Deka,et al.  Combinatorial therapeutic approach for treatment of oral squamous cell carcinoma , 2019, Artificial cells, nanomedicine, and biotechnology.

[16]  M. Anwer,et al.  Development and optimization of erythromycin-loaded lipid-based gel by Taguchi design: In vitro characterization and antimicrobial evaluation , 2019, Brazilian Journal of Pharmaceutical Sciences.

[17]  S. Shen,et al.  Effect of magnetic nanoparticles size on rheumatoid arthritis targeting and photothermal therapy. , 2018, Colloids and surfaces. B, Biointerfaces.

[18]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[19]  A. Saleh,et al.  Rheumatoid Arthritis: A Brief Overview of the Treatment , 2018, Medical Principles and Practice.

[20]  Bhupinder Singh,et al.  Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats , 2018, AAPS PharmSciTech.

[21]  Bhupinder Singh,et al.  Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats , 2018, AAPS PharmSciTech.

[22]  V. Garg,et al.  A Novel Three-pronged Approach for Colon Delivery of Sulfasalazine: Concomitant Use of pH- Responsive, Microbially Triggered Polymers and Liquisolid Technology. , 2018, Current Drug Delivery.

[23]  Upendra Nagaich,et al.  Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development. , 2018, Current Drug Delivery.

[24]  Upendra Nagaich,et al.  Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery , 2018 .

[25]  Seyedeh Sara Esnaashari,et al.  Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles , 2018, Advanced pharmaceutical bulletin.

[26]  F. Shabani,et al.  Central Composite Design Optimization of Zinc Removal from Contaminated Soil, Using Citric Acid as Biodegradable Chelant , 2018, Scientific Reports.

[27]  Zhirong Zhong,et al.  Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy , 2018, Drug delivery.

[28]  S. K. Singh,et al.  Review of Nanoemulsion Formulation and Characterization Techniques , 2018 .

[29]  V. Londhe,et al.  Zaltoprofen loaded solid lipid nanoparticles for topical delivery: formulation design, In vitro and Ex vivo evaluation , 2017 .

[30]  G. Patel,et al.  FORMULATION OPTIMIZATION AND CHARACTERIZATION OF GANCICLOVIR LOADED DRY CHITOSAN NANOPARTICLES , 2017 .

[31]  A. Madgulkar,et al.  Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis , 2017, Drug development and industrial pharmacy.

[32]  Y. Mehmood,et al.  Application of UV spectrophotometric method for easy and rapid estimation of sulfasalazine in pharmaceutical formulation (suspension) , 2017 .

[33]  N. Mondal,et al.  Optimisation using central composite design (CCD) and the desirability function for sorption of methylene blue from aqueous solution onto Lemna major , 2016 .

[34]  Upendra Nagaich,et al.  Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization , 2016, Drug Delivery and Translational Research.

[35]  N. Picci,et al.  Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery , 2016, Drug delivery.

[36]  Sacheen Kumar,et al.  Solid lipid nanoparticles of stearic acid for the drug delivery of paliperidone , 2015 .

[37]  Upendra Nagaich,et al.  Fabrication and in vitro characterization of polymeric nanoparticles for Parkinson's therapy: a novel approach , 2014 .

[38]  S. Saraf,et al.  Green Nanoparticle Strategies: Utilizing Excipients Sourced from Nature , 2014 .

[39]  P. R. Vuddanda,et al.  Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability , 2013, BioMed research international.

[40]  Upendra Nagaich,et al.  Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy , 2013, Scientia pharmaceutica.

[41]  D. Mcclements,et al.  Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). , 2009, Journal of colloid and interface science.

[42]  Y. Choi,et al.  Formulation of microemulsion systems for transdermal delivery of aceclofenac , 2005, Archives of pharmacal research.

[43]  G. Plosker,et al.  Sulfasalazine , 2012, Drugs.

[44]  Changsheng Xie,et al.  Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. , 2004, Biomaterials.

[45]  L. Brannon-Peppas Book reviewHandbook of pharmaceutical excipients: A. Wade and P.J. Weller (Eds.), 2nd Edn., 1994, American Pharmaceutical Association, Washington and The Pharmaceutical Press, London, 651 pages, £140.00 , 1996 .